Results
|
1581.
|
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. [electronic resource] by
- Motzer, Robert J
- Rini, Brian I
- McDermott, David F
- Arén Frontera, Osvaldo
- Hammers, Hans J
- Carducci, Michael A
- Salman, Pamela
- Escudier, Bernard
- Beuselinck, Benoit
- Amin, Asim
- Porta, Camillo
- George, Saby
- Neiman, Victoria
- Bracarda, Sergio
- Tykodi, Scott S
- Barthélémy, Philippe
- Leibowitz-Amit, Raya
- Plimack, Elizabeth R
- Oosting, Sjoukje F
- Redman, Bruce
- Melichar, Bohuslav
- Powles, Thomas
- Nathan, Paul
- Oudard, Stéphane
- Pook, David
- Choueiri, Toni K
- Donskov, Frede
- Grimm, Marc-Oliver
- Gurney, Howard
- Heng, Daniel Y C
- Kollmannsberger, Christian K
- Harrison, Michael R
- Tomita, Yoshihiko
- Duran, Ignacio
- Grünwald, Viktor
- McHenry, M Brent
- Mekan, Sabeen
- Tannir, Nizar M
Producer: 20200622
In:
The Lancet. Oncology vol. 20
Availability: No items available.
|
|
1582.
|
|
|
1583.
|
|
|
1584.
|
|
|
1585.
|
|
|
1586.
|
|
|
1587.
|
|
|
1588.
|
|
|
1589.
|
|
|
1590.
|
|
|
1591.
|
|
|
1592.
|
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study. [electronic resource] by
- Middleton, Mark R
- Dalle, Stéphane
- Claveau, Joel
- Mut, Pilar
- Hallmeyer, Sigrun
- Plantin, Patrice
- Highley, Martin
- Kotapati, Srividya
- Le, Trong Kim
- Brokaw, Jane
- Abernethy, Amy P
Producer: 20171116
In:
Cancer medicine vol. 5
Availability: No items available.
|
|
1593.
|
|
|
1594.
|
|
|
1595.
|
Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients. [electronic resource] by
- Gauci, Marie-Léa
- Boudou, Philippe
- Squara, Pierre-Alexandre
- Delyon, Julie
- Allayous, Clara
- Mourah, Samia
- Resche-Rigon, Matthieu
- Lebbé, Céleste
- Baroudjian, Barouyr
- Gautier, Jean-François
Producer: 20190911
In:
Melanoma research vol. 29
Availability: No items available.
|
|
1596.
|
|
|
1597.
|
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study. [electronic resource] by
- Ornstein, Moshe C
- Pal, Sumanta K
- Wood, Laura S
- Tomer, Jackie M
- Hobbs, Brian P
- Jia, Xuefei S
- Allman, Kimberly D
- Martin, Allison
- Olencki, Thomas
- Davis, Nancy B
- Gilligan, Timothy D
- Mortazavi, Amir
- Rathmell, W Kimryn
- Garcia, Jorge A
- Rini, Brian I
Producer: 20200622
In:
The Lancet. Oncology vol. 20
Availability: No items available.
|
|
1598.
|
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172). [electronic resource] by
- Schadendorf, Dirk
- Ascierto, Paolo A
- Haanen, John
- Espinosa, Enrique
- Demidov, Lev
- Garbe, Claus
- Guida, Michele
- Lorigan, Paul
- Chiarion-Sileni, Vanna
- Gogas, Helen
- Maio, Michele
- Fierro, Maria Teresa
- Hoeller, Christoph
- Terheyden, Patrick
- Gutzmer, Ralf
- Guren, Tormod K
- Bafaloukos, Dimitrios
- Rutkowski, Piotr
- Plummer, Ruth
- Waterston, Ashita
- Kaatz, Martin
- Mandala, Mario
- Marquez-Rodas, Ivan
- Muñoz-Couselo, Eva
- Dummer, Reinhard
- Grigoryeva, Elena
- Young, Tina C
- Nathan, Paul
Producer: 20200608
In:
European journal of cancer (Oxford, England : 1990) vol. 121
Availability: No items available.
|
|
1599.
|
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609. [electronic resource] by
- Tarhini, Ahmad A
- Lee, Sandra J
- Hodi, F Stephen
- Rao, Uma N M
- Cohen, Gary I
- Hamid, Omid
- Hutchins, Laura F
- Sosman, Jeffrey A
- Kluger, Harriett M
- Eroglu, Zeynep
- Koon, Henry B
- Lawrence, Donald P
- Kendra, Kari L
- Minor, David R
- Lee, Carrie B
- Albertini, Mark R
- Flaherty, Lawrence E
- Petrella, Teresa M
- Streicher, Howard
- Sondak, Vernon K
- Kirkwood, John M
Producer: 20200828
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|
|
1600.
|
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. [electronic resource] by
- Buckley, Hannah L
- Collinson, Fiona J
- Ainsworth, Gemma
- Poad, Heather
- Flanagan, Louise
- Katona, Eszter
- Howard, Helen C
- Murden, Geraldine
- Banks, Rosamonde E
- Brown, Joanne
- Velikova, Galina
- Waddell, Tom
- Fife, Kate
- Nathan, Paul D
- Larkin, James
- Powles, Thomas
- Brown, Sarah R
- Vasudev, Naveen S
Producer: 20200326
In:
BMC cancer vol. 19
Availability: No items available.
|